Neuroprotection of a novel synthetic caffeic acid-syringic acid hybrid compound against experimentally induced transient cerebral ischemic damage

Planta Medica

Volumn 79, Issue 5, 2013, Pages 313-321

  Kim, In Hye ^a   Yan, Bing Chun ^a   Park, Joon Ha ^a   Yeun, Go Heum ^b   Yim, Yongbae ^b   Ahn, Ji Hyeon ^c   Lee, Jae Chul ^a   Hwang, In Koo ^d   Cho, Jun Hwi ^a   Kim, Young Myeong ^e   Lee, Yun Lyul ^f   Park, Jeong Ho ^b   Won, Moo Ho ^a  

^a Kangwon National University   (South Korea)

^b Hanbat National University   (South Korea)

^c Daegu University   (South Korea)

^d Seoul National University   (South Korea)

^e Kangwon National University College of Medicine   (South Korea)

^f Hallym University   (South Korea)

Author keywords

hippocampus; ischemic stroke; natural phenolic compounds; neuroprotection

Indexed keywords

CAFFEIC ACID; SYRINGIC ACID; 4-(3-(2-(2-(4-ACETOXY-3,5-DIMETHOXYBENZOYLOXY)ETHOXY)ETHYLAMINO)-3-OXOPROP-1-ENYL)-1,2-PHENYLENE DIACETATE; CAFFEIC ACID DERIVATIVE; GALLIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN REGION; CELL ACTIVATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG SYNTHESIS; GERBIL; GLIA; GLIA CELL; HIPPOCAMPAL CA1 REGION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NEUROPROTECTION; NONHUMAN; PYRAMIDAL NERVE CELL; RAT; TRANSIENT ISCHEMIC ATTACK; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECTS; DRUG SCREENING; ISCHEMIC ATTACK, TRANSIENT; PATHOLOGY; SYNTHESIS;

GERBILLINAE;

ANIMALS; CA1 REGION, HIPPOCAMPAL; CAFFEIC ACIDS; DRUG EVALUATION, PRECLINICAL; GALLIC ACID; GERBILLINAE; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS;

EID: 84875758771     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0032-1328211     Document Type: Article

References (45)

1. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res: 1982; 239 57 69 (Pubitemid 12101768)
2. Schmidt-Kastner R., Freund T. F. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience: 1991; 40 599 636
3. Lin C. S., Polsky K., Nadler J. V., Crain B. J. Selective neocortical and thalamic cell death in the gerbil after transient ischemia. Neuroscience: 1990; 35 289 299 (Pubitemid 20176742)
4. Xu D., Du W., Zhao L., Davey A. K., Wang J. The neuroprotective effects of isosteviol against focal cerebral ischemia injury induced by middle cerebral artery occlusion in rats. Planta Med: 2008; 74 816 821 (Pubitemid 351991115)
5. Yao Y., Han D. D., Zhang T., Yang Z. Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons. Phytother Res: 2010; 24 136 140
6. Zhang H. F., Hu X. M., Wang L. X., Xu S. Q., Zeng F. D. Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway. Planta Med: 2009; 75 121 126
7. Nichiforesco E., Coucou V. [On the distribution of o-dihydroxyphenols of the caffeic acid type in the artichoke leaf and on their variation as a function of temperature]. Ann Pharm Fr: 1966; 24 127 132
8. Sondheimer E. On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch Biochem Biophys: 1958; 74 131 138
9. Ohtsuki T., Matsumoto M., Hayashi Y., Yamamoto K., Kitagawa K., Ogawa S., Yamamoto S., Kamada T. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol: 1995; 268 H1249 H1257
10. Yang J. Q., Zhou Q. X., Liu B. Z., He B. C. Protection of mouse brain from aluminum-induced damage by caffeic acid. CNS Neurosci Ther: 2008; 14 10 16
11. Koshihara Y., Neichi T., Murota S., Lao A., Fujimoto Y., Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta: 1984; 792 92 97 (Pubitemid 14180908)
12. Mehrotra A., Shanbhag R., Chamallamudi M. R., Singh V. P., Mudgal J. Ameliorative effect of caffeic acid against inflammatory pain in rodents. Eur J Pharmacol: 2011; 666 80 86
13. Irmak M. K., Fadillioglu E., Sogut S., Erdogan H., Gulec M., Ozer M., Yagmurca M., Gozukara M. E. Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct: 2003; 21 283 289 (Pubitemid 36988383)
14. Vieira O., Laranjinha J., Madeira V., Almeida L. Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate. Biochem Pharmacol: 1998; 55 333 340 (Pubitemid 28021746)
15. Hirota A., Taki S., Kawaii S., Yano M., Abe N. 1, 1-Diphenyl-2- picrylhydrazyl radical-scavenging compounds from soybean miso and antiproliferative activity of isoflavones from soybean miso toward the cancer cell lines. Biosci Biotechnol Biochem: 2000; 64 1038 1040
16. Kampa M., Alexaki V. I., Notas G., Nifli A. P., Nistikaki A., Hatzoglou A., Bakogeorgou E., Kouimtzoglou E., Blekas G., Boskou D., Gravanis A., Castanas E. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res: 2004; 6 R63 R74
17. Ramachandran V., Raja B. Protective effects of syringic acid against acetaminophen-induced hepatic damage in albino rats. J Basic Clin Physiol Pharmacol: 2010; 21 369 385
18. Zhou Y., Fang S. H., Ye Y. L., Chu L. S., Zhang W. P., Wang M. L., Wei E. Q. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol Sin: 2006; 27 1103 1110 (Pubitemid 44410989)
19. Seo J. Y., Lee C. H., Cho J. H., Choi J. H., Yoo K. Y., Kim D. W., Park O. K., Li H., Choi S. Y., Hwang I. K., Won M. H. Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes. J Neurol Sci: 2009; 285 88 94
20. Yoo K. Y., Li H., Hwang I. K., Choi J. H., Lee C. H., Kwon D. Y., Ryu S. Y., Kim Y. S., Kang I. J., Shin H. C., Won M. H. Zizyphus attenuates ischemic damage in the gerbil hippocampus via its antioxidant effect. J Med Food: 2010; 13 557 563
21. Yu J. T., Lee C. H., Yoo K. Y., Choi J. H., Li H., Park O. K., Yan B., Hwang I. K., Kwon Y. G., Kim Y. M., Won M. H. Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J Neurol Sci: 2010; 296 69 78
22. Hwang I. K., Yoo K. Y., Li H., Park O. K., Lee C. H., Choi J. H., Jeong Y. G., Lee Y. L., Kim Y. M., Kwon Y. G., Won M. H. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. J Neurosci Res: 2009; 87 2126 2137
23. Schmued L. C., Hopkins K. J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res: 2000; 874 123 130
24. Loskota W. J., Lomax P., Verity M. A. A stereotaxic atlas of the Mongolian gerbil brain (Meriones unguiculatus). Ann Arbor Ann Arbor Science: 1974
25. Wei X., Zhao L., Ma Z., Holtzman D. M., Yan C., Dodel R. C., Hampel H., Oertel W., Farlow M. R., Du Y. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain: 2004; 127 2629 2635 (Pubitemid 39627372)
26. Wang S. X., Guo H., Hu L. M., Liu Y. N., Wang Y. F., Kang L. Y., Gao X. M. Caffeic acid ester fraction from Erigeron breviscapus inhibits microglial activation and provides neuroprotection. Chin J Integr Med: 2012; 18 437 444
27. Jeong C. H., Jeong H. R., Choi G. N., Kim D. O., Lee U., Heo H. J. Neuroprotective and anti-oxidant effects of caffeic acid isolated from Erigeron annuus leaf. Chin Med: 2011; 6 25
28. Gulcin I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology: 2006; 217 213 220 (Pubitemid 41773837)
29. Kalkan Yildirim H., Delen Akcay Y., Guvenc U., Yildirim Sozmen E. Protection capacity against low-density lipoprotein oxidation and antioxidant potential of some organic and non-organic wines. Int J Food Sci Nutr: 2004; 55 351 362 (Pubitemid 39534693)
30. Chao C. C., Molitor T. W., Hu S. Neuroprotective role of IL-4 against activated microglia. J Immunol: 1993; 151 1473 1481 (Pubitemid 23219285)
31. Floyd R. A. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med: 1999; 222 236 245 (Pubitemid 129708638)
32. Fujimura M., Tominaga T., Chan P. H. Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis. Neurocrit Care: 2005; 2 59 66 (Pubitemid 40404630)
33. Zhang J., Li B., Liu J., Wang X., Wang Y., Li Y., Luo W. Synthesis of caffeic acid derivatives and their targeting on brain. Acta Academiae Medicinae Militaris Tertiae: 2010; 03 234 237
34. Zhao J., Pati S., Redell J. B., Zhang M., Moore A. N., Dash P. K. Caffeic acid phenethyl ester protects blood-brain barrier integrity and reduces contusion volume in rodent models of traumatic brain injury. J Neurotrauma: 2012; 29 1209 1218
35. Ordy J. M., Wengenack T. M., Bialobok P., Coleman P. D., Rodier P., Baggs R. B., Dunlap W. P., Kates B. Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Exp Neurol: 1993; 119 128 139 (Pubitemid 23074250)
36. Petito C. K., Halaby I. A. Relationship between ischemia and ischemic neuronal necrosis to astrocyte expression of glial fibrillary acidic protein. Int J Dev Neurosci: 1993; 11 239 247 (Pubitemid 23164316)
37. Steward O., Torre E. R., Tomasulo R., Lothman E. Seizures and the regulation of astroglial gene expression. Epilepsy Res Suppl: 1992; 7 197 209
38. Stoll G., Jander S., Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol: 1998; 56 149 171 (Pubitemid 28432563)
39. Park J. H., Joo H. S., Yoo K. Y., Shin B. N., Kim I. H., Lee C. H., Choi J. H., Byun K., Lee B., Lim S. S., Kim M. J., Won M. H. Extract from Terminalia chebula seeds protect against experimental ischemic neuronal damage via maintaining SODs and BDNF levels. Neurochem Res: 2011; 36 2043 2050
40. Hailer N. P., Jarhult J. D., Nitsch R. Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia: 1996; 18 319 331 (Pubitemid 27028297)
41. Schwartz M., Butovsky O., Bruck W., Hanisch U. K. Microglial phenotype: is the commitment reversible? Trends Neurosci: 2006; 29 68 74
42. Hwang I. K., Yoo K. Y., Kim D. W., Choi S. Y., Kang T. C., Kim Y. S., Won M. H. Ionized calcium-binding adapter molecule 1 immunoreactive cells change in the gerbil hippocampal CA1 region after ischemia/reperfusion. Neurochem Res: 2006; 31 957 965 (Pubitemid 44134250)
43. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A: 1998; 95 15769 15774 (Pubitemid 29018775)
44. Woo Y. J., Lee B. H., Yeun G. H., Kim H. J., Won M. H., Kim S. H., Lee B. H., Park J. H. Selective butyrylcholinesterase inhibitors using polyphenol-polyphenol hybrid molecules. Bull Korean Chem Soc: 2011; 8 2593
45. Yamasaki Y., Matsuura N., Shozuhara H., Onodera H., Itoyama Y., Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke: 1995; 26 676 680 discussion 681